Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Unterrainer

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Neurology|May 22, 2019
Teaching NeuroImages: Advanced imaging of neurosarcoidosis with <sup>68</sup>Ga-DOTATATE PET/CTMarcus Unterrainer, Viktoria Ruf, Harun Ilhan, et al.
Journal of Neuro-Oncology|June 28, 2018
<sup>18</sup>F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapyBogdana Suchorska, Marcus Unterrainer, Annamaria Biczok, et al.
Neuro-Oncology|September 11, 2019
Comment on "Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?"Norbert Galldiks, Antoine Verger, Timothée Zaragori, et al.
BMC Cancer|February 8, 2021
The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective studyVera Wenter, Nathalie L Albert, Freba Ahmaddy, et al.
Diagnostics (Basel, Switzerland)|March 11, 2023
Finger Pain as an Uncommon Primary Manifestation of Lung CarcinomaAdrien Holzgreve, Hans Roland Dürr, Axel Stäbler, et al.
JAMA Dermatology|October 19, 2022
Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced MelanomaZachary Cartun, Wolfgang G Kunz, Lucie Heinzerling, et al.
Journal of Neurology|July 25, 2022
Acetyl-DL-leucine in cerebellar ataxia ([<sup>18</sup>F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?Sandra Becker-Bense, Lena Kaiser, Regina Becker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Cost-Effectiveness of [<sup>177</sup>Lu]Lu-DOTATATE for the Treatment of Newly Diagnosed Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Analysis Based on Results of the NETTER-2 TrialAdrien Holzgreve, Lena M Unterrainer, Maximilian Tiling, et al.
Clinical Nuclear Medicine|March 5, 2019
68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural MetastasesMarcus Unterrainer, Viktoria Ruf, Harun Ilhan, et al.
Neuro-Oncology|October 11, 2017
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytomaBogdana Suchorska, Armin Giese, Annamaria Biczok, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Neurology|May 22, 2019
Teaching NeuroImages: Advanced imaging of neurosarcoidosis with <sup>68</sup>Ga-DOTATATE PET/CTMarcus Unterrainer, Viktoria Ruf, Harun Ilhan, et al.
Journal of Neuro-Oncology|June 28, 2018
<sup>18</sup>F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapyBogdana Suchorska, Marcus Unterrainer, Annamaria Biczok, et al.
Neuro-Oncology|September 11, 2019
Comment on "Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?"Norbert Galldiks, Antoine Verger, Timothée Zaragori, et al.
BMC Cancer|February 8, 2021
The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective studyVera Wenter, Nathalie L Albert, Freba Ahmaddy, et al.
Diagnostics (Basel, Switzerland)|March 11, 2023
Finger Pain as an Uncommon Primary Manifestation of Lung CarcinomaAdrien Holzgreve, Hans Roland Dürr, Axel Stäbler, et al.
JAMA Dermatology|October 19, 2022
Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced MelanomaZachary Cartun, Wolfgang G Kunz, Lucie Heinzerling, et al.
Journal of Neurology|July 25, 2022
Acetyl-DL-leucine in cerebellar ataxia ([<sup>18</sup>F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?Sandra Becker-Bense, Lena Kaiser, Regina Becker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Cost-Effectiveness of [<sup>177</sup>Lu]Lu-DOTATATE for the Treatment of Newly Diagnosed Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Analysis Based on Results of the NETTER-2 TrialAdrien Holzgreve, Lena M Unterrainer, Maximilian Tiling, et al.
Clinical Nuclear Medicine|March 5, 2019
68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural MetastasesMarcus Unterrainer, Viktoria Ruf, Harun Ilhan, et al.
Neuro-Oncology|October 11, 2017
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytomaBogdana Suchorska, Armin Giese, Annamaria Biczok, et al.
Pageof 17